St. George's Hospital, London
16
2
4
5
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 16 trials
100.0%
+13.5% vs industry average
13%
2 trials in Phase 3/4
20%
1 of 5 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (16)
Distribution of Cell-cell Junction Proteins in Arrhythmic Disorders
Role: lead
Controlled Trial of High-risk Coronary Intervention With Percutaneous Left Ventricular Unloading
Role: collaborator
Hybrid Ablation of Atrial Fibrillation in Heart Failure
Role: lead
Tumor Rupture During Robotic Partial Nephrectomy
Role: collaborator
Digital Diet and Exercise Intervention to Reduce Liver Fibrosis in Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD)
Role: lead
MYOPROSP - a Prospective Cohort Study in Myositis
Role: collaborator
Treg Immunotherapy in Crohn's Disease
Role: collaborator
Genetic Determinants of Kawasaki Disease
Role: collaborator
A Prospective UK Multicentre Study of Kidney Donors
Role: collaborator
Toward Self-management in ILD
Role: collaborator
Indexed Aortic Area in Bicuspid Aortic Valve Aortopathy
Role: lead
Pre-oxygenation With High-flow Nasal Cannula in Adults During Rapid Sequence Induction Anesthesia
Role: collaborator
Improving Oesophageal Protection During AF Ablation
Role: lead
Trial of Adaptive Deep Brain Stimulation
Role: lead
Cryotherapy Versus Radiofrequency Catheter Ablation Research Program
Role: lead
Spectroscopy With Surface Coils and Decoupling
Role: collaborator
All 16 trials loaded